US Patent 8865732 Heterocyclic compounds and uses thereof
Patent 8865732 was granted and assigned to Novartis on October, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Infobox
Patent Inventor Names
Aaron Smith0
Cynthia Shafer0
Daniel Poon0
Jeff Jin0
Martin Sendzik0
Maureen McKenna0
Paul A. Renhowe0
Qiong Zhang0
Timothy Machajewski0
William R. Antonios-McCrea0
Yongjin Xu0
Zheng Chen0
Zilin Huang0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08865732 Heterocyclic compounds and uses thereof US Patent 8865732 Heterocyclic compounds and uses thereof
Infobox
Patent Number
08865732
Patent Number
8865732
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 27 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08865732 Heterocyclic compounds and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08865732
Date of patent
October 21, 2014
Patent application number
13396339
Date Filed
February 14, 2012
Patent primary examiner
Find more entities like US Patent 8865732 Heterocyclic compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
